Brussels, 1st December 2011 – Ansell Healthcare, a global leader in healthcare barrier protection, today announced the European launch of its GAMMEX® Powder-Free gloves with AMT Antimicrobial Technology. It is the first surgical glove to incorporate a proprietary antimicrobial coating that provides an additional level of protection to surgical staff against viruses and bacteria, in the event of a breach during surgery. Following its successful launch in Australian hospitals in 2010, European healthcare providers can now also benefit from the added safety and comfort provided by GAMMEX® Powder-Free gloves with AMT.
Healthcare systems around the world have been substantially improved by making healthcare workers aware that gloves provide effective protection against contamination from bacteria and viruses. “Despite rigorous infection control measures, surgical teams remain exposed to the risk of contamination in cases of glove perforation,” said Marcus Heimann, Marketing Director – Medical Solutions EMEA & India, Ansell Healthcare. “GAMMEX® Powder-Free with AMT acts like a second skin, with its own immune system to further protect surgical teams against harmful pathogens. Ansell is proud to present this new powerful protection to our customers.”
Unlike gloves without AMT technology, GAMMEX® has the power to protect healthcare providers from contamination in two ways – the barrier and the active antimicrobial coating, which acts like an invisible backup system in case of breach.
A study led by Dr. Heidi Misteli*, University Hospital Basel, Switzerland, revealed that 1 in 3 gloves were perforated during surgical procedures, potentially exposing healthcare providers to pathogens such as HIV or Hepatitis C and drug-resistant bacteria. By adding an additional safety mechanism to the gloves, in the form of an antimicrobial coating, the risks of contamination are significantly reduced, providing surgical teams with peace of mind and the sense of security that is needed to maintain their professional focus.
Made of natural rubber latex, the gloves also provide enhanced sensitivity and low allergenicity, creating a new standard for the surgical glove industry.
To experience the glove live, Ansell invites interested parties to the product’s presentation at the following trade shows:
* Dr. Heidi Misteli et al., ARCH SURG/VOL 144 (NO. 6), June 2009
GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the skin is broken, cut or punctured.
GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.
Australia Patent No. 703926 and New Zealand Patent No. 556353. AU and worldwide patents pending.
Ansell, ® and ™ are trademarks owned by Ansell Limited or one of its affiliates.
© 2011 Ansell Limited. All rights reserved.
For the press pack and photographs, please click here: http://www.anselleurope.com/medical/index.cfm?page=gammex_pf_amt&lang=EN
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. With operations in North America, Latin America, EMEA and Asia, Ansell employs more than 10,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, New Verticals and Sexual Wellness. Information on Ansell and its products can be found at http://www.ansell.eu
Marketing Communications Manager EMEA, Ansell Healthcare
Tel: +32 (0)2 529 8308